HARBOR INVESTMENT ADVISORY, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
HARBOR INVESTMENT ADVISORY, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$2,000
-77.8%
10
-83.3%
0.00%
-100.0%
Q2 2022$9,000
-87.1%
60
-89.8%
0.00%
-88.9%
Q1 2022$70,000
-13.6%
5870.0%0.01%
-10.0%
Q4 2021$81,000
+24.6%
587
+25.4%
0.01%
+11.1%
Q3 2021$65,000
+85.7%
468
+31.1%
0.01%
+80.0%
Q2 2021$35,000
+3400.0%
357
+3470.0%
0.01%
Q1 2021$1,0000.0%100.0%0.00%
Q4 2020$1,00010
+66.7%
0.00%
Q2 2020$060.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders